Protein palmitoylation in cancer: molecular functions and therapeutic potential

Protein S‐palmitoylation (hereinafter referred to as protein palmitoylation) is a reversible lipid posttranslational modification catalyzed by the zinc finger DHHC‐type containing (ZDHHC) protein family. The reverse reaction, depalmitoylation, is catalyzed by palmitoyl‐protein thioesterases (PPTs),...

Full description

Bibliographic Details
Main Authors: Binhui Zhou, Qianyun Hao, Yinming Liang, Eryan Kong
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Molecular Oncology
Subjects:
Online Access:https://doi.org/10.1002/1878-0261.13308
_version_ 1797961299678724096
author Binhui Zhou
Qianyun Hao
Yinming Liang
Eryan Kong
author_facet Binhui Zhou
Qianyun Hao
Yinming Liang
Eryan Kong
author_sort Binhui Zhou
collection DOAJ
description Protein S‐palmitoylation (hereinafter referred to as protein palmitoylation) is a reversible lipid posttranslational modification catalyzed by the zinc finger DHHC‐type containing (ZDHHC) protein family. The reverse reaction, depalmitoylation, is catalyzed by palmitoyl‐protein thioesterases (PPTs), including acyl‐protein thioesterases (APT1/2), palmitoyl protein thioesterases (PPT1/2), or alpha/beta hydrolase domain‐containing protein 17A/B/C (ABHD17A/B/C). Proteins encoded by several oncogenes and tumor suppressors are modified by palmitoylation, which enhances the hydrophobicity of specific protein subdomains, and can confer changes in protein stability, membrane localization, protein–protein interaction, and signal transduction. The importance for protein palmitoylation in tumorigenesis has just started to be elucidated in the past decade; palmitoylation appears to affect key aspects of cancer, including cancer cell proliferation and survival, cell invasion and metastasis, and antitumor immunity. Here we review the current literature on protein palmitoylation in the various cancer types, and discuss the potential of targeting of palmitoylation enzymes or palmitoylated proteins for tumor treatment.
first_indexed 2024-04-11T00:56:49Z
format Article
id doaj.art-aff7ac389f314689b431524ece95b62a
institution Directory Open Access Journal
issn 1574-7891
1878-0261
language English
last_indexed 2024-04-11T00:56:49Z
publishDate 2023-01-01
publisher Wiley
record_format Article
series Molecular Oncology
spelling doaj.art-aff7ac389f314689b431524ece95b62a2023-01-05T03:41:33ZengWileyMolecular Oncology1574-78911878-02612023-01-0117132610.1002/1878-0261.13308Protein palmitoylation in cancer: molecular functions and therapeutic potentialBinhui Zhou0Qianyun Hao1Yinming Liang2Eryan Kong3Institute of Psychiatry and Neuroscience Xinxiang Medical University ChinaKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Oncology II Peking University Cancer Hospital & Institute Beijing ChinaInstitute of Psychiatry and Neuroscience Xinxiang Medical University ChinaInstitute of Psychiatry and Neuroscience Xinxiang Medical University ChinaProtein S‐palmitoylation (hereinafter referred to as protein palmitoylation) is a reversible lipid posttranslational modification catalyzed by the zinc finger DHHC‐type containing (ZDHHC) protein family. The reverse reaction, depalmitoylation, is catalyzed by palmitoyl‐protein thioesterases (PPTs), including acyl‐protein thioesterases (APT1/2), palmitoyl protein thioesterases (PPT1/2), or alpha/beta hydrolase domain‐containing protein 17A/B/C (ABHD17A/B/C). Proteins encoded by several oncogenes and tumor suppressors are modified by palmitoylation, which enhances the hydrophobicity of specific protein subdomains, and can confer changes in protein stability, membrane localization, protein–protein interaction, and signal transduction. The importance for protein palmitoylation in tumorigenesis has just started to be elucidated in the past decade; palmitoylation appears to affect key aspects of cancer, including cancer cell proliferation and survival, cell invasion and metastasis, and antitumor immunity. Here we review the current literature on protein palmitoylation in the various cancer types, and discuss the potential of targeting of palmitoylation enzymes or palmitoylated proteins for tumor treatment.https://doi.org/10.1002/1878-0261.13308cancer treatmentoncogeneprotein S‐palmitoylationtumor suppressortumorigenesis
spellingShingle Binhui Zhou
Qianyun Hao
Yinming Liang
Eryan Kong
Protein palmitoylation in cancer: molecular functions and therapeutic potential
Molecular Oncology
cancer treatment
oncogene
protein S‐palmitoylation
tumor suppressor
tumorigenesis
title Protein palmitoylation in cancer: molecular functions and therapeutic potential
title_full Protein palmitoylation in cancer: molecular functions and therapeutic potential
title_fullStr Protein palmitoylation in cancer: molecular functions and therapeutic potential
title_full_unstemmed Protein palmitoylation in cancer: molecular functions and therapeutic potential
title_short Protein palmitoylation in cancer: molecular functions and therapeutic potential
title_sort protein palmitoylation in cancer molecular functions and therapeutic potential
topic cancer treatment
oncogene
protein S‐palmitoylation
tumor suppressor
tumorigenesis
url https://doi.org/10.1002/1878-0261.13308
work_keys_str_mv AT binhuizhou proteinpalmitoylationincancermolecularfunctionsandtherapeuticpotential
AT qianyunhao proteinpalmitoylationincancermolecularfunctionsandtherapeuticpotential
AT yinmingliang proteinpalmitoylationincancermolecularfunctionsandtherapeuticpotential
AT eryankong proteinpalmitoylationincancermolecularfunctionsandtherapeuticpotential